Membranous Nephropathy: Clinical Trials

2 trials for Membranous Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Membranous Nephropathy: new trials by email Literature Review of Membranous Nephropathy trials Research Report on Membranous Nephropathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adrenocorticotropic Hormone in Membranous Nephropathy
ACTHar - Membranous Nephropathy
Phase 4CompletedIcahn School of Medicine at Mount Sinai52018-03-192022-08-15
To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
TW - Membranous Nephropathy
Phase 4CompletedNanjing University School of Medicine682007-07-012010-05-27

Narrower conditions

Glomerulonephritis, Membranous (2)  ·  Proteinuria (2)  ·  Glomerulonephritis (1)

Broader conditions

Autoimmune Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Immune System Diseases (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Nephritis (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Urination Disorders (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Urological Manifestations (2)  ·  Glomerulonephritis (1)

Interventions

Adrenocorticotropic Hormone (1)

Sponsors

Icahn School of Medicine at Mount Sinai (1)  ·  Nanjing University School of Medicine (1)

Countries

China (1)  ·  United States (1)

Top investigators

Paolo Cravedi, MD, PhD (1)  ·  Zhihong Liu, Master (1)

Results publications

PMID 34778952